592 related articles for article (PubMed ID: 34006959)
1. Advances in targeting 'undruggable' transcription factors with small molecules.
Henley MJ; Koehler AN
Nat Rev Drug Discov; 2021 Sep; 20(9):669-688. PubMed ID: 34006959
[TBL] [Abstract][Full Text] [Related]
2. Current strategies and progress for targeting the "undruggable" transcription factors.
Zhuang JJ; Liu Q; Wu DL; Tie L
Acta Pharmacol Sin; 2022 Oct; 43(10):2474-2481. PubMed ID: 35132191
[TBL] [Abstract][Full Text] [Related]
3. Frontiers in PROTACs.
Hughes GR; Dudey AP; Hemmings AM; Chantry A
Drug Discov Today; 2021 Oct; 26(10):2377-2383. PubMed ID: 33872800
[TBL] [Abstract][Full Text] [Related]
4. Reimagining Druggability Using Chemoproteomic Platforms.
Spradlin JN; Zhang E; Nomura DK
Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
[TBL] [Abstract][Full Text] [Related]
5. Drug-Induced Expression-Based Computational Repurposing of Small Molecules Affecting Transcription Factor Activity.
Gayvert K; Elemento O
Methods Mol Biol; 2019; 1903():179-184. PubMed ID: 30547442
[TBL] [Abstract][Full Text] [Related]
6. Protein degradation technology: a strategic paradigm shift in drug discovery.
Li H; Dong J; Cai M; Xu Z; Cheng XD; Qin JJ
J Hematol Oncol; 2021 Sep; 14(1):138. PubMed ID: 34488823
[TBL] [Abstract][Full Text] [Related]
7. Principles for targeting RNA with drug-like small molecules.
Warner KD; Hajdin CE; Weeks KM
Nat Rev Drug Discov; 2018 Aug; 17(8):547-558. PubMed ID: 29977051
[TBL] [Abstract][Full Text] [Related]
8. Targeted Protein Degradation: An Important Tool for Drug Discovery for "Undruggable" Tumor Transcription Factors.
Dai M; Radhakrishnan S; Li R; Tan R; Yan K; Fan G; Liu M
Technol Cancer Res Treat; 2022; 21():15330338221095950. PubMed ID: 35466792
[TBL] [Abstract][Full Text] [Related]
9. PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery.
Gu S; Cui D; Chen X; Xiong X; Zhao Y
Bioessays; 2018 Apr; 40(4):e1700247. PubMed ID: 29473971
[TBL] [Abstract][Full Text] [Related]
10. Drugging the 'undruggable'. Therapeutic targeting of protein-DNA interactions with the use of computer-aided drug discovery methods.
Radaeva M; Ton AT; Hsing M; Ban F; Cherkasov A
Drug Discov Today; 2021 Nov; 26(11):2660-2679. PubMed ID: 34332092
[TBL] [Abstract][Full Text] [Related]
11. Strategies for targeting undruggable targets.
Zhang G; Zhang J; Gao Y; Li Y; Li Y
Expert Opin Drug Discov; 2022 Jan; 17(1):55-69. PubMed ID: 34455870
[TBL] [Abstract][Full Text] [Related]
12. Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders.
Hughes SJ; Ciulli A
Essays Biochem; 2017 Nov; 61(5):505-516. PubMed ID: 29118097
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Quantitative Assay Technologies for Accelerating the Discovery and Optimization of Targeted Protein Degradation Therapeutics.
Simard JR; Lee L; Vieux E; Improgo R; Tieu T; Phillips AJ; Fisher SL; Pollock RM; Park E
SLAS Discov; 2021 Apr; 26(4):503-517. PubMed ID: 33430712
[TBL] [Abstract][Full Text] [Related]
14. Targeted protein knockdown using small molecule degraders.
Raina K; Crews CM
Curr Opin Chem Biol; 2017 Aug; 39():46-53. PubMed ID: 28605671
[TBL] [Abstract][Full Text] [Related]
15. Targeting Undruggable Transcription Factors with PROTACs: Advances and Perspectives.
Li Y; Song J; Zhou P; Zhou J; Xie S
J Med Chem; 2022 Aug; 65(15):10183-10194. PubMed ID: 35881047
[TBL] [Abstract][Full Text] [Related]
16. Targeting post-translational modification of transcription factors as cancer therapy.
Qian M; Yan F; Yuan T; Yang B; He Q; Zhu H
Drug Discov Today; 2020 Aug; 25(8):1502-1512. PubMed ID: 32540433
[TBL] [Abstract][Full Text] [Related]
17. Targeting RNA structures in diseases with small molecules.
Shao Y; Zhang QC
Essays Biochem; 2020 Dec; 64(6):955-966. PubMed ID: 33078198
[TBL] [Abstract][Full Text] [Related]
18. Small-Molecule Degraders beyond PROTACs-Challenges and Opportunities.
Kastl JM; Davies G; Godsman E; Holdgate GA
SLAS Discov; 2021 Apr; 26(4):524-533. PubMed ID: 33632029
[TBL] [Abstract][Full Text] [Related]
19. Drug target miRNAs: chances and challenges.
Schmidt MF
Trends Biotechnol; 2014 Nov; 32(11):578-585. PubMed ID: 25304465
[TBL] [Abstract][Full Text] [Related]
20. Targeting small GTPases and their downstream pathways with intracellular macromolecule binders to define alternative therapeutic strategies in cancer.
Sorbara M; Bery N
Biochem Soc Trans; 2021 Nov; 49(5):2021-2035. PubMed ID: 34623375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
